Imagine if high volume and viscosity biologics could be self- injected with increased confidence and reduced patient anxiety.
Chronic disease management is undergoing a paradigm shift towards self-management. Needle-anxiety, frequent injections, and device complexity can lead to poor compliance and sub-optimal therapeutic benefit indicating an unmet need for innovative injection systems.
Our range of self-injectors can adapt to meet your delivery needs
Benefits of our devices
Significant volume and viscosity capabilities (≤2 mL, up to 60 cP)
Faster injection times/ reduced hold times
Low-cost, highly scalable
Improved Patient Compliance and Experience
Microneedles reduce needle-anxiety and pain perception
Complete Dose Delivery
Near 100% of the dose is delivered to the intended depth
Various embodiments for different patient populations
Simple to use devices improve injection confidence Emerging evidence indicates a potential therapeutic benefit to the intradermal delivery of biologics:
Pharmacokinetics
- Increased bioavailability (vs subcutaneous injection)
- Faster absorption
- Increased Cmax
Efficacy
- Enhanced efficacy due to efficient lymphatic trafficking
- Reduced systemic A/E’s
- Improved anti-tumour activity